M.R. Noori-Daloii Academic Experience and Research Activities:
M.R. Noori-Daloii Academic Experience and Research Activities:
M.R. Noori-Daloii Academic Experience and Research Activities:
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
77. Mesbah Namin S.A., Sanati, M.H. Mowjoodi,A.R., <strong>and</strong> <strong>Noori</strong>-<strong>Daloii</strong>,M.R.(Oct.2001).<br />
Identification of three Genetic Variants of G6PD Enzyme in Favism Patients in Maz<strong>and</strong>aran., 6th<br />
Conference on Biochemistry, Iranian Society of Biochemistry <strong>and</strong> Univ. of Iran Medical Sciences,<br />
Tehran, I.R. Iran, PP.397- 398(Presentation).<br />
78. Mesbah Namin S.A., Sanati, M.H. Mowjoodi,A.R., <strong>and</strong> <strong>Noori</strong>-<strong>Daloii</strong>,M.R.(Sept.2001).<br />
Identification of Molecular Mutations of Glucose-6- Phosphate Dehydrogenase (G6PD) Gene in<br />
Deficient Patients in state of Maz<strong>and</strong>aran., The 10th Iranian Biology Conference, Iranian Society of<br />
Biology <strong>and</strong> Shiraz Univ, Shiraz, I.R.Iran, PP.144-145 (Presentation).<br />
79. <strong>Noori</strong>-<strong>Daloii</strong>,M.R. (Dec.2001).Genetic Engineering <strong>and</strong> Gene therapy – Challenges <strong>and</strong> its<br />
Prospective (guest Speaker).Fourth <strong>Research</strong> Week <strong>and</strong> post – graduates, Univ.of Esfehan, Esfehan ,<br />
I.r.Iran, pp.46-74 (full Presentation).<br />
80. Heidari, M.M., Sadeghi Zadeh, M., <strong>Noori</strong>-<strong>Daloii</strong>,M.R. (Feb. 2002). Molecular<br />
Comparison of Herpes Simplex Virus (HSV-1) Genomes Isolated from Iranian Patients With KOS<br />
Strain Via The Amplification of UL29 Gene (DNA B<strong>and</strong>ing Protein). 1<br />
30<br />
st Iranian congeress on Virology.<br />
Iranian Society of virology <strong>and</strong> Tehran Univ. of Medical Sciences, Tehran, I.R. Iran,<br />
PP. 40-41.( Presentation).<br />
81. <strong>Noori</strong>-<strong>Daloii</strong>,M.R. (May,2002)., Colonization <strong>and</strong> Gene Therapy (guest Speaker). 1st Symposium<br />
on colonization <strong>and</strong> Gene Therapy, Babol Univ.of Medical Sciences, I.R. Iran (Full Presentation).<br />
82.<strong>Noori</strong>-<strong>Daloii</strong>,M.R.(DEC.2002).Medical Genetics:importance <strong>and</strong> applications<br />
(guest Speaker). Seminar in Medical Genetics <strong>and</strong> molecular Preventation, UNIV. of Mashad Medical<br />
Sciences, Mashad,I.R.Iran,PP. 1-15 (full presentation).<br />
83. <strong>Noori</strong>-<strong>Daloii</strong>,M.R.(DEC.2002).Principle <strong>and</strong> basis of Gene therapy- Challenges <strong>and</strong><br />
Hopes(guest Speaker). Seminar in Medical Genetics <strong>and</strong> molecular Preventation, UNIV. of Mashad<br />
Medical Sciences, Mashad,I.R.Iran . PP.44-59(Full presentation).<br />
84. <strong>Noori</strong>- <strong>Daloii</strong> M.R., Najafi L. Hajebrahimi Z., Mohammad Ganji S. <strong>and</strong> Sanati M.H. (Dec.2002).<br />
Detecting the most prevalence of mutation in G6PD gene in Gilan <strong>and</strong> Golestan provinces of Iran. 2 nd<br />
Iranian Congress of Genetic Disorders & Disabilities (ICGDD); The Social Welfare <strong>and</strong> Rehabilitation<br />
Sciences University, With Collaboration of other Universities <strong>Research</strong> Institutions, Tehran, I.R. Iran .<br />
(presentation).<br />
85. <strong>Noori</strong>- <strong>Daloii</strong> M.R., Hajebrahimi , Z. Najafi, L. Mohammad Ganji, S. Sadeghizadeh, M.<br />
(May,2003). Determination of mutations in G6PD gene in Northern parts of Iran. ESHG 2003-<br />
European Society of Human Genetics, European Human Genetics Conference Birmingham , Engl<strong>and</strong>.<br />
(Poster ), PP.167-168.<br />
86. <strong>Noori</strong>-<strong>Daloii</strong> M.R.,(Jul.2003).Challenges in Scientific development in Iran (guest speaker) ,<br />
Iranian Society of Biology <strong>and</strong> Ministry of Science, <strong>Research</strong> <strong>and</strong> Technology, Tehran, I.R. Iran, PP.,1-<br />
14(full presentation).<br />
87. <strong>Noori</strong>- <strong>Daloii</strong> M.R.,Hajebrahimi,Z, Najafi,L , Mohammad Ganji, S. Sadeghizadeh, M. <strong>and</strong><br />
Sanati, M.H. (23-25Aug.2003). Molecular analysis of the most prevalence mutation G6PD gene in<br />
deficient patients in states of Gilan <strong>and</strong> Golestanin Iran. Thell th Iranian Biology conference, Iranian<br />
Society of Biology <strong>and</strong> Urmia University, Urmia, I.R. Iran. PP.103 <strong>and</strong> 499.(Presentation).<br />
88. <strong>Noori</strong>- <strong>Daloii</strong> M.R., Hajebrahimi , Z. Najafi, L. Mohammad Ganji, S., Sadeghizadeh, M., <strong>and</strong><br />
Sanati, M.H. (Dec.2003). Distribution of G6PD Mutation in Iran- States of Gilan <strong>and</strong> Golestan , Al –<br />
Ain International Genetics Congress, United Arab Emarates Univ, Dubai, UAE.(Poster).<br />
89. <strong>Noori</strong>-<strong>Daloii</strong>,M.R., Mohammad Ganji, S., Najafi, L., Hajebrahihi, Z., Sadeghizadeh, M., <strong>and</strong><br />
Sanati, M.H., (June 2004). Molecular Genetics of G6PD <strong>and</strong> Determination of two kinds of Mutations<br />
in G6PD Gene in a Family in State of Golestan. 36 th European Genetics conference, Munich,<br />
Germany. (Poster). Published in European J. of Human Genetics, vol. 12- Supplement 1-Junel 2004,P<br />
217.<br />
90. <strong>Noori</strong>-<strong>Daloii</strong>,M.R., Shahabi, M., Jahanzad, E., Khoshbin, E., Taghikhani, M., Field, J., Langan,<br />
J., <strong>and</strong> Risk. J.(Sept.2004). An Investigation on Status of Tylosis with Oesophageal Cancer (TOC)<br />
Locus ir Iranian Patients Afflicted with Esophageal Squamous Cell Carcinoma. 15 th International<br />
Chromosome Conference (ICCXV)., Brunel Univ. in West London, London, Engl<strong>and</strong>.(poster).Published<br />
in Chromosome <strong>Research</strong>, vol. 12 Supplement 1, 2004, PP.30-31.